Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades.

Novel management options have been explored for GEP-NENs with more specific inclusion criteria during the past two decades. More efforts are needed to promote international collaborations in clinical trials and enhance timely result dissemination.